270
Participants
Start Date
October 7, 2019
Primary Completion Date
February 15, 2024
Study Completion Date
August 29, 2024
Vitamin C
Vitamine C will be administered intravenously as ascorbic acid (ascorbinezuur CF 100 mg/ml, Centrafarm BV, Etten Leur, Netherlands).
Thiamine
All patients will receive thiamine 200 mg q 12 hourly for 4 days to limit the conversion of vitamin C to oxalate.
Placebos
One group receives a placebo.
VU Medical Center, Amsterdam
Collaborators (1)
Gelderse Vallei Hospital
OTHER
Sint Franciscus Gasthuis
OTHER
Tergooiziekenhuizen
UNKNOWN
Amphia Hospital
OTHER
Erasmus Medical Center
OTHER
Noordwest Ziekenhuisgroep
OTHER
Maasstad Hospital
OTHER
OLVG
NETWORK
Amsterdam UMC, location VUmc
OTHER